Search
Selected Filters
Filter Results
Displaying 41–50 of 267 research results
-
Aug 25, 2022
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
The company’s drug is designed to reduce accumulation of toxins that cause vision loss.
-
Aug 11, 2022
ProQR Seeking to Partner Ophthalmic Programs
The company is halting its clinical programs for LCA10 and USH2A as it seeks a new partner
-
Aug 10, 2022
Funding for the new grants was made possible by Foundation’s strong donor base and philanthropic partners
-
Jul 25, 2022
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases
-
Jul 22, 2022
Apellis’ Treatment for Advanced Dry AMD to Receive Priority Review from FDA
There are currently no FDA-approved therapies for geographic atrophy (GA), the advanced form of dry AMD.
-
Jul 14, 2022
Endogena Launches Clinical Trial of Therapy to Activate Stem Cells in RP Patients’ Retinas
The emerging treatment is gene-agnostic.
-
Jun 27, 2022
Kiora to Launch Clinical Trial in Australia for Vision-Restoring Small Molecule for RP Patients
The approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
-
Jun 20, 2022
The newly approved drug reduces the pathologic hunger associated with BBS
-
Jun 13, 2022
Over Thirty Presentations Highlighted during the 2022 Retinal Cell & Gene Therapy Innovation Summit
In its seventh year, the Retinal Cell & Gene Therapy Innovation Summit featured 34 presentations from industry experts from around the world.
-
May 24, 2022
Luxa Doses First Participant in Clinical Trial of RPE Stem Cells for Dry AMD Patients
The company’s RPESC-RPE cell product is composed of progenitor-stage RPE cells grown from human eyes donated to eye banks.